Table 1 Baseline characteristics of patients seen in French hospitals in 2013 with at least 5 years of follow-up (mean follow-up 4.8 ± 1.7 years, median 5.5, IQR 5.1–5.8 years) according to sex and diabetes
|  | Women (n = 1,596,521) | Men (n = 1,324,886) | p | Total (n = 2,921,407) |
|---|---|---|---|---|
Age, years | 57.4 ± 20.2 | 62.4 ± 15.7 |  < 0.0001 | 59.7 ± 18.5 |
Hypertension | 394,909 (24.7) | 414,073 (31.3) |  < 0.0001 | 808,982 (27.7) |
Type 1 diabetes mellitus | 21,440 (1.3) | 23,949 (1.8) |  < 0.0001 | 45,389 (1.6) |
Type 2 diabetes mellitus | 158,536 (9.9) | 186,963 (14.1) |  < 0.0001 | 345,499 (11.8) |
Heart failure | 78,953 (4.9) | 118,967 (9.0) |  < 0.0001 | 197,920 (6.8) |
History of pulmonary edema | 6134 (0.4) | 8133 (0.6) |  < 0.0001 | 14,267 (0.5) |
Valve disease | 31,293 (2.0) | 33,494 (2.5) |  < 0.0001 | 64,787 (2.2) |
Aortic stenosis | 12,777 (0.8) | 15,286 (1.2) |  < 0.0001 | 28,063 (1.0) |
Aortic regurgitation | 5961 (0.4) | 6842 (0.5) |  < 0.0001 | 12,803 (0.4) |
Mitral regurgitation | 11,861 (0.7) | 11,598 (0.9) |  < 0.0001 | 23,459 (0.8) |
Previous endocarditis | 719 (0.0) | 1715 (0.1) |  < 0.0001 | 2434 (0.1) |
Dilated cardiomyopathy | 15,679 (1.0) | 25,281 (1.9) |  < 0.0001 | 40,960 (1.4) |
Coronary artery disease | 80,028 (5.0) | 180,628 (13.6) |  < 0.0001 | 260,656 (8.9) |
Previous myocardial infarction | 13,781 (0.9) | 29,458 (2.2) |  < 0.0001 | 43,239 (1.5) |
Previous PCI | 17,071 (1.1) | 54,082 (4.1) |  < 0.0001 | 71,153 (2.4) |
Previous CABG | 1332 (0.1) | 5455 (0.4) |  < 0.0001 | 6787 (0.2) |
Vascular disease | 66,211 (4.1) | 152,831 (11.5) |  < 0.0001 | 219,042 (7.5) |
Sinus node disease | 4839 (0.3) | 6677 (0.5) |  < 0.0001 | 11,516 (0.4) |
Previous pacemaker or ICD | 18,282 (1.1) | 35,437 (2.7) |  < 0.0001 | 53,719 (1.8) |
Ischemic stroke | 18,064 (1.1) | 24,153 (1.8) |  < 0.0001 | 42,217 (1.4) |
Intracranial bleeding | 11,518 (0.7) | 15,023 (1.1) |  < 0.0001 | 26,541 (0.9) |
Smoker | 77,467 (4.9) | 130,941 (9.9) |  < 0.0001 | 208,408 (7.1) |
Dyslipidemia | 154,413 (9.7) | 204,085 (15.4) |  < 0.0001 | 358,498 (12.3) |
Obesity | 173,764 (10.9) | 124,824 (9.4) |  < 0.0001 | 298,588 (10.2) |
Alcohol related diagnoses | 43,979 (2.8) | 123,782 (9.3) |  < 0.0001 | 167,761 (5.7) |
Chronic kidney disease | 36,061 (2.3) | 47,271 (3.6) |  < 0.0001 | 83,332 (2.9) |
Diabetic retinopathy | 13,416 (0.8) | 16,111 (1.2) |  < 0.0001 | 29,527 (7.6) |
Lung disease | 113,325 (7.1) | 146,430 (11.1) |  < 0.0001 | 259,755 (8.9) |
Sleep apnea syndrome | 40,091 (2.5) | 67,314 (5.1) |  < 0.0001 | 107,405 (3.7) |
COPD | 46,967 (2.9) | 92,916 (7.0) |  < 0.0001 | 139,883 (4.8) |
Liver disease | 37,124 (2.3) | 61,683 (4.7) |  < 0.0001 | 98,807 (3.4) |
Gastroesophageal reflux | 55,429 (3.5) | 43,668 (3.3) |  < 0.0001 | 99,097 (3.4) |
Thyroid diseases | 111,988 (7.0) | 27,696 (2.1) |  < 0.0001 | 139,684 (4.8) |
Inflammatory disease | 84,357 (5.3) | 66,951 (5.1) |  < 0.0001 | 151,308 (5.2) |
Anaemia | 115,265 (7.2) | 96,982 (7.3) | 0.001 | 212,247 (7.3) |
Previous cancer | 197,346 (12.4) | 245,236 (18.5) |  < 0.0001 | 442,582 (15.1) |
Poor nutrition | 50,124 (3.1) | 46,689 (3.5) |  < 0.0001 | 96,813 (3.3) |
Cognitive impairment | 48,277 (3.0) | 35,666 (2.7) |  < 0.0001 | 83,943 (2.9) |
Illicit drug use | 4036 (0.3) | 9041 (0.7) |  < 0.0001 | 13,077 (0.4) |